+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Identification of CANT1 mutations in Desbuquois dysplasia



Identification of CANT1 mutations in Desbuquois dysplasia



American Journal of Human Genetics 85(5): 706-710



Desbuquois dysplasia is a severe condition characterized by short stature, joint laxity, scoliosis, and advanced carpal ossification with a delta phalanx. Studying nine Desbuquois families, we identified seven distinct mutations in the Calcium-Activated Nucleotidase 1 gene (CANT1), which encodes a soluble UDP-preferring nucleotidase belonging to the apyrase family. Among the seven mutations, four were nonsense mutations (Del 5' UTR and exon 1, p.P245RfsX3, p.S303AfsX20, and p.W125X), and three were missense mutations (p.R300C, p.R300H, and p.P299L) responsible for the change of conserved amino acids located in the seventh nucleotidase conserved region (NRC). The arginine substitution at position 300 was identified in five out of nine families. The specific function of CANT1 is as yet unknown, but its substrates are involved in several major signaling functions, including Ca2+ release, through activation of pyrimidinergic signaling. Importantly, using RT-PCR analysis, we observed a specific expression in chondrocytes. We also found electron-dense material within distended rough endoplasmic reticulum in the fibroblasts of Desbuquois patients. Our findings demonstrate the specific involvement of a nucleotidase in the endochondral ossification process.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053658546

Download citation: RISBibTeXText

PMID: 19853239

DOI: 10.1016/j.ajhg.2009.10.001


Related references

Mutation of CANT1 causes Desbuquois dysplasia. American Journal of Medical Genetics. Part a 152a(5): 1157-1160, 2010

CANT1 mutation is also responsible for Desbuquois dysplasia, type 2 and Kim variant. Journal of Medical Genetics 48(1): 32-37, 2011

A novel CANT1 mutation in three Indian patients with Desbuquois dysplasia Kim type. European Journal of Medical Genetics 58(2): 105-110, 2015

A compound heterozygote of novel and recurrent DTDST mutations results in a novel intermediate phenotype of Desbuquois dysplasia, diastrophic dysplasia, and recessive form of multiple epiphyseal dysplasia. Journal of Human Genetics 53(8): 764-768, 2008

A phenotype intermediate between Desbuquois dysplasia and diastrophic dysplasia secondary to mutations in DTDST. American Journal of Medical Genetics. Part a 146a(22): 2920-2924, 2008

XYLT1 mutations in Desbuquois dysplasia type 2. American Journal of Human Genetics 94(3): 405-414, 2014

Case of Desbuquois dysplasia type 1: potentially lethal skeletal dysplasia. Pediatrics International 56(4): E26-E29, 2014

A case of skeletal dysplasia with advanced carpal ossification and monkey wrench appearance of the femora; Mild Desbuquois dysplasia?. European Journal Of Pediatrics. 155(12): 1040-1042, 1996

A recurrence of a hydrop lethal skeletal dysplasia showing similarity to Desbuquois dysplasia and a proposed new sign: the Upsilon sign. American Journal of Medical Genetics. Part a 152a(4): 966-969, 2010

Lethality in Desbuquois dysplasia: three new cases. Pediatric Radiology 31(1): 43-47, 2001

A novel syndrome resembling Desbuquois dysplasia. American Journal of Medical Genetics. Part A 132a(1): 68-75, 2004

A mild variant of Desbuquois dysplasia. European Journal of Pediatrics 158(6): 479-483, 1999

Clinical and genetic heterogeneity in Desbuquois dysplasia. American Journal of Medical Genetics. Part a 128a(1): 29-32, 2004